COMMUNIQUÉS West-GlobeNewswire

Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
10/03/2026
NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.’s Class A common stock by [...]
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
10/03/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
10/03/2026
MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
10/03/2026
Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 ( [...]
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
10/03/2026
LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
10/03/2026
Initial clinical response data for AlloNK ® in refractory rheumatoid arthritis (RA) expected in first half of 2026 U.S. Food and Drug Administration (FDA) interaction to discuss potential pivotal trial design for AlloNK [...]
Orion Corporation: Managers’ transactions – René Lindell
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – René Lindell Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026
10/03/2026
Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Orion Corporation: Managers’ transactions – Satu Ahomäki
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Liisa Hurme
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Virbac : Déclaration d'actions et de droits de vote 02/2026
10/03/2026
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares and voting rights 02/2026
10/03/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26
10/03/2026
March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health [...]
MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs
10/03/2026
MAPS delegation includes senior researchers, policy experts, and Veterans from the US, Europe, Australia, and the Middle East. The CND is a central drug policy-making body in the UN, playing the leading role in [...]
Orion Corporation: Managers’ transactions – Julia Macharey
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Julia Macharey Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
Orion Corporation: Managers’ transactions – Hao Pan
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Hao Pan Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/ [...]
HOOPP delivers strong 2025 results for Ontario’s healthcare community
10/03/2026
Net assets reach $132 billion, with nearly half invested in Canada, and membership now exceeding 500,000 TORONTO, March 10, 2026 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan’s net assets grew to $132 [...]
Orion Corporation: Managers’ transactions – Niclas Lindstedt
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers’ transactions – Mikko Kemppainen
10/03/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 10 MARCH 2026 at 17.00 EET Orion Corporation: Managers’ transactions – Mikko Kemppainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]

Pages